Clinical Trial Update: Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating voclosporin in combination with tacrolimus for kidney transplantation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• LUPKYNIS (voclosporin)
• Prograf (Tacrolimus)

Snippet

Sponsor: Aurinia Pharmaceuticals Inc. | Conditions: Renal Transplantation | Phase 3 | Status: WITHDRAWN